Imaging Mass Cytometry
Imaging Mass Cytometry (IMC) is a multiplexed proteomics technique that maps the subcellular localization of up to 40-50 proteins in tissue sections simultaneously using mass spectrometry detection. Developed by Bodenmiller and colleagues in 2014, IMC combines the single-cell imaging power of immunofluorescence with the multiplexing capacity of mass cytometry, enabling comprehensive analysis of cell types, states, and spatial interactions within tissue microenvironments. IMC has emerged as a powerful tool in immuno-oncology, immunobiology, and tissue biology for dissecting cellular heterogeneity and spatial organization.
Source record
Citations copied verbatim from the method’s source record. No claim-level verification is inferred from them.
- Giesen, C., Wang, H. A., Schapiro, D., et al. (2014). Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nature Methods, 11(4), 417-422. · DOI 10.1038/nmeth.2869
- Jackson, H. W., Fischer, J. R., Zanotelli, V. R., et al. (2020). The single-cell pathology of synovial inflammation in rheumatoid arthritis. Nature Medicine, 26(6), 941-951. · URL
- Schulz, D., Zanotelli, V. R., Fischer, J. R., et al. (2018). Simultaneous multiplexed imaging of mRNA and proteins with subcellular resolution in breast cancer tissue samples by imaging mass cytometry. Nature Protocols, 13(12), 2825-2848. · DOI 10.1016/j.cels.2018.04.004
Curated claims
Claims persisted in the evidence ledger, each with its own assessment.
This view does not invent a claim assessment when the ledger has none.
Related methods
Generated from the method graph and shown as machine-suggested relations — no evidence claim is inferred.